ZYFLO CR (Chiesi USA, Inc.)


Welcome to the PulseAid listing for the ZYFLO CR drug offered from Chiesi USA, Inc.. This 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Chiesi USA, Inc.
NON-PROPRIETARY NAME: zileuton
SUBSTANCE NAME: ZILEUTON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, MULTILAYER, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-05-30
END MARKETING DATE: 0000-00-00


ZYFLO CR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZYFLO CR from Chiesi USA, Inc.
LABELER NAME: Chiesi USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 600(mg/1)
START MARKETING DATE: 2007-05-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10122-902_73d2e42b-eba3-40fa-b1f8-2159cf49e41a
PRODUCT NDC: 10122-902
APPLICATION NUMBER: NDA022052

Other ZILEUTON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Chiesi USA, Inc.ZYFLO
Prasco, LLCZileuton
Rising Pharmaceuticals, Inc.Zileuton